Value of Enhancer of Zeste Homolog 2 (EZH2) for Determining Prognosis in Colon Cancer
Introduction: It has been reported that Enhancer of Zeste Homolog 2 (EZH2) enhancer is expressed in Colorectal Cancer (CRC), but there are only limited findings of its overexpression with prognosis in CRC. Aim: To investigate the association between EZH2 expression and clinicopathologic variables a...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2020-03-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/13559/43176_CE[Ra1]_F(KM)_PF1_(AJ_OM)_PN(SL).pdf |